Cargando…

Clinical utility of asthma biomarkers: from bench to bedside

Asthma is a chronic disease characterized by airway inflammation, bronchial hyperresponsiveness, and recurrent episodes of reversible airway obstruction. The disease is very heterogeneous in onset, course, and response to treatment, and seems to encompass a broad collection of heterogeneous disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vijverberg, Susanne JH, Hilvering, Bart, Raaijmakers, Jan AM, Lammers, Jan-Willem J, Maitland-van der Zee, Anke-Hilse, Koenderman, Leo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762671/ https://www.ncbi.nlm.nih.gov/pubmed/24009412 http://dx.doi.org/10.2147/BTT.S29976

Ejemplares similares

Phenotyping asthma using an unsupervised prediction model based on blood granulocyte responsiveness
por: Hilvering, Bart, et al.
Publicado: (2015)

Inflammatory phenotypes underlying uncontrolled childhood asthma despite inhaled corticosteroid treatment: rationale and design of the PACMAN2 study
por: Vijverberg, Susanne JH, et al.
Publicado: (2013)

Identification of inflammatory phenotypes of asthma by blood analysis and clinical parameters
por: Hilvering, Bart, et al.
Publicado: (2013)

Asthmatic children that are uncontrolled despite inhaled corticosteroids have a distinct breathprint (the pacman2 study)
por: Vijverberg, Susanne, et al.
Publicado: (2015)

Similar activation of sputum granulocytes in eosinophilic and non-eosinophilic asthma
por: Hilvering, Bart, et al.
Publicado: (2015)

Precision medicine in severe pediatric asthma: opportunities and challenges
por: Vijverberg, Susanne J.H., et al.
Publicado: (2020)

Characteristics and severity of asthma in children with and without atopic conditions: a cross-sectional study
por: Arabkhazaeli, Ali, et al.
Publicado: (2015)

Developments in the Management of Severe Asthma in Children and Adolescents: Focus on Dupilumab and Tezepelumab
por: van Dijk, Yoni E., et al.
Publicado: (2023)

Childhood asthma in the new omics era: challenges and perspectives
por: Golebski, Korneliusz, et al.
Publicado: (2020)

Identifying risk factors for COPD and adult-onset asthma: an umbrella review
por: Holtjer, Judith C.S., et al.
Publicado: (2023)

Editorial: The utilization of bench-to-bedside approaches in pharmacogenomics
por: Rytkin, Eric, et al.
Publicado: (2023)

Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022)

The crosstalk between microbiome and asthma: Exploring associations and challenges
por: Abdel‐Aziz, Mahmoud I., et al.
Publicado: (2019)

Bench and Bedside
por: Schmidt, Christian
Publicado: (2002)

Sonochemotherapy: from bench to bedside
por: Lammertink, Bart H. A., et al.
Publicado: (2015)

The Influence of Smoking Status on Exhaled Breath Profiles in Asthma and COPD Patients
por: Principe, Stefania, et al.
Publicado: (2021)

Persistence of parental‐reported asthma at early ages: A longitudinal twin study
por: Slob, Elise Margaretha Adriana, et al.
Publicado: (2022)

Validation of volatile metabolites of pulmonary oxidative injury: a bench to bedside study
por: Fenn, Dominic, et al.
Publicado: (2023)

COVID-19 and thrombosis: From bench to bedside
por: Ali, Mohammad A.M., et al.
Publicado: (2021)

Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review
por: Zazuli, Zulfan, et al.
Publicado: (2018)

From bench to bedside
por: Verdant, Colin L
Publicado: (2012)

Genetic associations of the response to inhaled corticosteroids in asthma: a systematic review
por: Keskin, Ozlem, et al.
Publicado: (2019)

Exhaled volatile organic compounds associated with risk factors for obstructive pulmonary diseases: a systematic review
por: Shahbazi Khamas, Shahriyar, et al.
Publicado: (2023)

Pharmacogenetics and pharmacogenomics: practical applications in routine medical practice
por: Maitland-van der Zee, Anke-Hilse, et al.
Publicado: (2010)

FCER2 T2206C variant associated with FENO levels in asthmatic children using inhaled corticosteroids: The PACMAN study
por: Karimi, Leila, et al.
Publicado: (2019)

From bedside to bench to clinic trials: identifying new treatments for severe asthma
por: Mishra, Amarjit, et al.
Publicado: (2013)

Bench-to-bedside review: Genetic influences on meningococcal disease
por: Vermont, Clementien L, et al.
Publicado: (2002)

Sepsis: From Bench to Bedside
por: Silva, Eliézer, et al.
Publicado: (2008)

Nutrition: From Bench to Bedside
por: Khan, Naim A., et al.
Publicado: (2016)

Linagliptin: from bench to bedside
por: Doupis, John
Publicado: (2014)

Pruritus: From the Bench to the Bedside
por: Reich, Adam, et al.
Publicado: (2018)

Silver linings at the bench and bedside
por: Katz, Steven C., et al.
Publicado: (2020)

Olutasidenib: from bench to bedside
por: Venugopal, Sangeetha, et al.
Publicado: (2023)

Comparison of Myelotoxicity and Nephrotoxicity Between Daily Low-Dose Cisplatin With Concurrent Radiation and Cyclic High-Dose Cisplatin in Non-Small Cell Lung Cancer Patients
por: Zazuli, Zulfan, et al.
Publicado: (2020)

Bench-To-Bedside and Bedside Back to the Bench; Coordinating Clinical and Experimental Traumatic Brain Injury Studies
por: Agoston, Denes V., et al.
Publicado: (2012)

Bench-to-bedside review: Hypercapnic acidosis in lung injury - from 'permissive' to 'therapeutic'
por: Ijland, Marloes M, et al.
Publicado: (2010)

Bench-to-bedside review: An approach to hemodynamic monitoring - Guyton at the bedside
por: Magder, Sheldon
Publicado: (2012)

Research in Sickle Cell Disease: From Bedside to Bench to Bedside
por: Salinas Cisneros, Gabriel, et al.
Publicado: (2021)

Editorial: Cerebral and spinal vascular malformations: from bench to bedside
por: Ma, Li, et al.
Publicado: (2023)

30 years hids—Travels between bedside and bench
por: van der Meer, Jos W M
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6p1ctfk6mf0b2prs06sch3rdhr